跳至主要内容
临床试验/IRCT20151226025699N3
IRCT20151226025699N3招募中未知

The effect of omega-3 supplementation on inflammatory and biochemical markers in critical ill patients with COVID-19 a randomized clinical trial

Sabzevar University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 85 years(—)
性别
All

入选标准

  • Written consent for participation
  • Age over 34 years
  • A diagnosis of COVID-19 based on symptoms such as severe pneumonia, fever, fatigue, dry cough, respiratory distress, and lungs involvement in the computed tomographic (CT) scan according to the doctor's confirmation

排除标准

  • Not tendency to continue participating in the study
  • Diagnosed cardiovascular and lung diseases which can disturb the study process
  • A diagnosis of malignant tumors
  • Recent use of chemotherapy drugs
  • Having incomplete medical records
  • Non-compliance with the omega-3 supplementation
  • Consumption of omega-3 fatty acids supplementation during the last 3-month before the study

研究者

发起方
Sabzevar University of Medical Sciences

相似试验